Silverfin false 31/03/2023 01/04/2022 31/03/2023 Dr B Crockett 23/07/2015 Dr A A Forbes 05/08/2015 Dr R Gupta 04/08/2023 23/07/2015 Dr R Kilfeather 01/08/2019 Dr J A Stewart 23/07/2015 14 November 2023 SO305417 2023-03-31 SO305417 bus:Director1 2023-03-31 SO305417 bus:Director2 2023-03-31 SO305417 bus:Director3 2023-03-31 SO305417 bus:Director4 2023-03-31 SO305417 bus:Director5 2023-03-31 SO305417 2022-03-31 SO305417 core:CurrentFinancialInstruments 2023-03-31 SO305417 core:CurrentFinancialInstruments 2022-03-31 SO305417 core:FurnitureFittings 2022-03-31 SO305417 core:FurnitureFittings 2023-03-31 SO305417 2022-04-01 2023-03-31 SO305417 bus:FullAccounts 2022-04-01 2023-03-31 SO305417 bus:SmallEntities 2022-04-01 2023-03-31 SO305417 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 SO305417 bus:LimitedLiabilityPartnershipLLP 2022-04-01 2023-03-31 SO305417 bus:Director1 2022-04-01 2023-03-31 SO305417 bus:Director2 2022-04-01 2023-03-31 SO305417 bus:Director3 2022-04-01 2023-03-31 SO305417 bus:Director4 2022-04-01 2023-03-31 SO305417 bus:Director5 2022-04-01 2023-03-31 SO305417 core:FurnitureFittings 2022-04-01 2023-03-31 SO305417 2021-04-01 2022-03-31 SO305417 core:CurrentFinancialInstruments 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Company No: SO305417 (Scotland)

SCOTSTOWN DYCE LLP

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH THE REGISTRAR

SCOTSTOWN DYCE LLP

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023

Contents

SCOTSTOWN DYCE LLP

BALANCE SHEET

AS AT 31 MARCH 2023
SCOTSTOWN DYCE LLP

BALANCE SHEET (continued)

AS AT 31 MARCH 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 6,001 7,060
6,001 7,060
Current assets
Debtors 4 19,971 5,020
Cash at bank and in hand 288,822 156,707
308,793 161,727
Creditors: amounts falling due within one year 5 ( 314,794) ( 168,787)
Net current liabilities (6,001) (7,060)
Total assets less current liabilities 0 0
Net assets attributable to members 0 0

For the financial year ending 31 March 2023 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

Members' responsibilities:

Scotstown Dyce LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

The financial statements of Scotstown Dyce LLP (registered number: SO305417) were approved and authorised for issue by the Director on 14 November 2023. They were signed on its behalf by:

Dr A A Forbes
Designated member
SCOTSTOWN DYCE LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
SCOTSTOWN DYCE LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Scotstown Dyce LLP is a limited liability partnership, incorporated in the United Kingdom under the Limited Liability Partnerships Act 2000 and is registered in Scotland. The address of the LLP's registered office is Medical Centre, Cairnfold Road, Bridge Of Don, Aberdeen, AB22 8LD, United Kingdom.

The financial statements have been prepared under the historical cost convention, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Limited Liability Partnerships Act 2000 as applicable to companies subject to the small companies regime and the requirements of the Statement of Recommended Practice Accounting by Limited Liability Partnerships issued in December 2021 (SORP 2022).

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover represents amounts earned during the year from medical activities.

If, at the balance sheet date, completion of contractual obligations is dependent on external factors (and thus outside of the control of the Limited Liability Partnership), then revenue is recognised only when the event occurs. In such cases, costs incurred up to the balance sheet date are carried forward as work in progress.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Taxation

The taxation payable on the partnership's profits is the personal liability of the members, although payment of such liabilities is administered by the partnership on behalf of its members. Consequently, neither partnership taxation nor related deferred taxation is accounted for in these financial statements. Sums set aside in respect of members' tax obligations are included in the balance sheet within loans and other debts due to members, or are set against amounts due from members as appropriate.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases


The LLP as lessor
Rental income from operating leases is recognised on a straight-line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Equity instruments
Equity instruments issued by the LLP are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the LLP.

Members' participation rights

Member's participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).

Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with FRS 25 (IAS 32) Financial Instruments: Disclosure and Presentation and UITF abstract 39 Members' shares in co-operative entities and similar instruments. A members' participation right results in a liability unless the right to any payment is discretionary on the part of the LLP.

Amounts subscribed or otherwise contributed by members, for example members' capital, are classed as equity if the LLP has an unconditional right to refuse payments to members. If the LLP does not have such an unconditional right, such amounts are classified as liabilities.

The profits are not automatically divided as they arise, the LLP therefore has an unconditional right to refuse payment of the profits for a particular year unless and until those profits are divided by a decision taken by the members; and accordingly, following such a division, those profits are classed as an appropriation or equity rather than an expense. They are therefore shown as a residual amount available for appropriation in the Profit and Loss Account.

All amounts due to members that are classified as liabilities are presented in the Statement of Financial Position within 'Loans and other debts due to members' and are charged to the Profit and Loss Account within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the Statement of Financial Position within 'Members' other interests'.

Pensions

The pension cost charged in the financial statements represents the contributions payable by the partnership during the year.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the LLP during the year 29 29

3. Tangible assets

Fixtures and fittings Total
£ £
Cost
At 01 April 2022 19,249 19,249
At 31 March 2023 19,249 19,249
Accumulated depreciation
At 01 April 2022 12,189 12,189
Charge for the financial year 1,059 1,059
At 31 March 2023 13,248 13,248
Net book value
At 31 March 2023 6,001 6,001
At 31 March 2022 7,060 7,060

4. Debtors

2023 2022
£ £
Trade debtors 3,361 4,256
Other debtors 16,610 764
19,971 5,020

5. Creditors: amounts falling due within one year

2023 2022
£ £
Trade creditors 64,219 37,068
Other taxation and social security 414 16,677
Other creditors 250,161 115,042
314,794 168,787

There are no amounts included above in respect of which any security has been given by the small entity.

6. Related party transactions

Other related party transactions

2023 2022
£ £
Scotstown Medical Practice 250,161 115,042